Rp-8-CPT-cAMPS (sodium)
Rp-8-CPT-cAMPS sodium, a cAMP analog, is a potent and competitive antagonist of cAMP-induced activation of cAMP-dependent PKA I and II. Rp-8-CPT-cAMPS sodium preferentially selects site A of RI compares to site A of RII and site B of RII compares to site B of RI[1][2].
Product Specifications
CAS Number
221905-35-7
UNSPSC
12352005
Target
PKA
Type
Reference compound
Related Pathways
Stem Cell/Wnt; TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/rp-8-cpt-camps-sodium.html
Purity
99.0
Solubility
DMF : 30 mg/mL (ultrasonic; warming)
Smiles
O[C@H]1[C@](O[C@@](CO2)([H])[C@@]1([H])O[P@@]2([S-])=O)([H])N3C4=NC=NC(N)=C4N=C3SC(C=C5)=CC=C5Cl.[Na+]
Molecular Formula
C16H14ClN5NaO5PS2
Molecular Weight
509.86
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Eosinophil Peroxidase (AHE-1), CF740 conjugate, 0.1mg/mL
Pgp9.5 (UCHL-1) (31A3), CF740 conjugate, 0.1mg/mL
HCG-beta (hCGb/459), CF740 conjugate, 0.1mg/mL
